Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus

1.

Kronsbein P, Schlemper N (2022) Pilotstudie zu den Effekten eines individualisierten Gewichtsreduktionsprogramms mit mehreren strukturiert vermittelten Methoden zur Gewichtsabnahme (#44). Abstracts des Adipositas-Kongresses 2022 zur 38. Jahrestagung Dtsch Adipositas Ges E V Dag Adipositas – Ursachen Folgeerkrankungen Ther 3:183–184

2.

Lean MEJ, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, clusterrandomised trial. Lancet 391:541–551PubMedCrossRef

3.

McGlynn ND, Khan TA, Wang L et al (2022) Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and meta-analysis. JAMA Netw Open 5:e222092PubMedPubMedCentralCrossRef

4.

Le Ma H, Yang A, Derrick J et al (2023) Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study. BMJ 381:e73406PubMedPubMedCentralCrossRef

5.

Salari A, Ghodrat S, Gheflati A et al (2021) Effect of kefir beverage consumption on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Clin Pract 44:101443PubMedCrossRef

6.

Beck J, Greenwood DA, Blanton L et al (2017) 2017 national standards for diabetes self-management education and support. Diabetes Care 40:1409–1419PubMedCrossRef

7.

Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754PubMedPubMedCentralCrossRef

8.

(2019) Ausschuss Ernährung der Deutschen Diabetes Gesellschaft (DDG). Stellungnahme zu Evert AB et al Consensus Report: Nutrition Therapy for Adults with Diabetes or Prediabetes. Diabetes Care. https://www.deutsche-diabetes-gesellschaft.de/politik/stellungnahmen/stellungnahmedes-ausschuss-ernaehrung-der-ddg-zum-consensusreport-nutrition-the-rapy-for-adults-with-diabetes-or-prediabetes

9.

DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368PubMedCrossRef

10.

DeFronzo RA, Eldor R, Abdul-Ghani M (2013) Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 36(Suppl. 02):S127–S138PubMedPubMedCentralCrossRef

11.

Lencioni C, Lupi R, Del Prato S (2008) Beta-cell failure in type 2 diabetes mellitus. Curr Diab Rep 8:179–184PubMedCrossRef

12.

Anonymous (1995) U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study. Group Diabetes 44:1249–1258CrossRef

13.

Zaharia OP, Strassburger K, Strom A et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7:684–694PubMedCrossRef

14.

Kodama S, Horikawa C, Fujihara K et al (2014) Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis. Obes Rev 15:202–214PubMedCrossRef

15.

Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:1481–1486PubMedPubMedCentralCrossRef

16.

Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39:808–815PubMedCrossRef

17.

Jazet IM, Pijl H, Frölich M et al (2005) Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients. Diabet Med 22:52–55PubMedCrossRef

18.

Bangalore S, Fayyad R, DeMicco DA et al (2018) Body weight variability and cardiovascular outcomes in patients with type 2 diabetes mellitus. Circ Cardiovasc Qual Outcomes 11:e4724PubMedCrossRef

19.

Yeboah P, Hsu FC, Bertoni AG et al (2019) Body mass index, change in weight, body weight variability and outcomes in type 2 diabetes mellitus (from the ACCORD trial). Am J Cardiol 123:576–581PubMedCrossRef

20.

Pagidipati NJ, Zheng Y, Green JB et al (2020) Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. Am Heart J 219:47–57PubMedCrossRef

21.

Bodegard J, Sundström J, Svennblad B et al (2013) Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab 39:306–313PubMedCrossRef

22.

Weinheimer EM, Sands LP, Campbell WW (2010) A systematic review of the separate and combined effects of energy restriction and exercise on fatfree mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev 68:375–388PubMedCrossRef

23.

Zaccardi F, Dhalwani NN, Papamargaritis D et al (2017) Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414587 participants in prospective studies. Diabetologia 60:240–248PubMedCrossRef

24.

Salehidoost R, Mansouri A, Amini M et al (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577PubMedCrossRef

25.

Hainer V, Aldhoon-Hainerová I (2013) Obesity paradox does exist. Diabetes Care 36(Suppl. 02):S276–S281PubMedPubMedCentralCrossRef

26.

Murphy RA, Reinders I, Garcia ME et al (2014) Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care 37:3213–3219PubMedPubMedCentralCrossRef

27.

Bales CW, Porter Starr KN (2018) Obesity interventions for older adults: diet as a determinant of physical function. Adv Nutr 9:151–159PubMedPubMedCentralCrossRef

28.

Uusitupa M, Khan TA, Viguiliouk E et al (2019) Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis. Nutrients 11:2611PubMedPubMedCentralCrossRef

29.

Raben A, Vestentoft PS, Brand-Miller J et al (2021) The PREVIEW intervention study: results from a 3-year randomized 2 × 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes. Diabetes Obes Metab 23:324–337PubMedCrossRef

30.

Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496PubMedPubMedCentralCrossRef

31.

Anderson JW, Konz EC, Frederich RC et al (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74:579–584PubMedCrossRef

32.

Bundesgesundheitsministerium (2015) Telemedizin. https://www.bundesgesundheitsministerium.de/service/begriffe-von-a-z/t/telemedizin.html. Zugegriffen: 9. Apr. 2021

33.

Su D, McBride C, Zhou J et al (2016) Does nutritional counseling in telemedicine improve treatment outcomes for diabetes? A systematic review and meta-analysis of results from 92 studies. J Telemed Telecare 22:333–347PubMedCrossRef

34.

Kempf K, Altpeter B, Berger J et al (2017) Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care 40:863–871PubMedCrossRef

35.

Colquitt JL, Pickett K, Loveman E et al (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD3641

36.

Templeman I, Smith HA, Chowdhury E et al (2021) A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults. Sci Transl Med 13:eabd8034PubMedCrossRef

37.

Patel KV, Bahnson JL, Gaussoin SA et al (2020) Association of baseline and longitudinal changes in body composition measures with risk of heart failure and myocardial infarction in type 2 diabetes: findings from the look AHEAD trial. Circulation 142:2420–2430PubMedPubMedCentralCrossRef

38.

Franz MJ, Boucher JL, Rutten-Ramos S et al (2015) Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115:1447–1463PubMedCrossRef

39.

Murgatroyd PR, Goldberg GR, Leahy FE et al (1999) Effects of inactivity and diet composition on human energy balance. Int J Obes Relat Metab Disord 23:1269–1275PubMedCrossRef

40.

Stubbs RJ, Sepp A, Hughes DA et al (2002) The effect of graded levels of exercise on energy intake and balance in free-living women. Int J Obes Relat Metab Disord 26:866–869PubMedCrossRef

41.

Granados K, Stephens BR, Malin SK et al (2012) Appetite regulation in response to sitting and energy imbalance. Appl Physiol Nutr Metab 37:323–333PubMedCrossRef

42.

Hägele FA, Büsing F, Nas A et al (2019) Appetite control is improved by acute increases in energy turnover at different levels of energy balance. J Clin Endocrinol Metab 104:4481–4491PubMedCrossRef

43.

Douglas JA, King JA, Clayton DJ et al (2017) Acute effects of exercise on appetite, ad libitum energy intake and appetite-regulatory hormones in lean and overweight/obese men and women. Int J Obes 41:1737–1744CrossRef

44.

Savikj M, Zierath JR (2020) Train like an athlete: applying exercise interventions to manage type 2 diabetes. Diabetologia 63:1491–1499PubMedPubMedCentralCrossRef

45.

Büsing F, Hägele FA, Nas A et al (2019) Impact of energy turnover on the regulation of glucose homeostasis in healthy subjects. Nutr Diabetes 9:22PubMedPubMedCentralCrossRef

46.

Larsen JJ, Dela F, Kjaer M et al (1997) The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 40:447–453PubMedCrossRef

47.

Heden TD, Winn NC, Mari A et al (1985) Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes. J Appl Physiol 2015(118):624–634

48.

Reynolds AN, Mann JI, Williams S et al (2016) Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia 59:2572–2578PubMedCrossRef

49.

Gaudet-Savard T, Ferland A, Broderick TL et al (2007) Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 14:831–836PubMedCrossRef

50.

DiPietro L, Gribok A, Stevens MS et al (2013) Three 15-min bouts of moderate postmeal walking significantly improves 24‑h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care 36:3262–3268PubMedPubMedCentralCrossRef

51.

Seidelmann SB, Claggett B, Cheng S et al (2018) Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health 3:e419–e428PubMedPubMedCentralCrossRef

52.

Davies MJ, D’Alessio DA, Fradkin J et al (2018) Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41:2669–2701PubMedPubMedCentralCrossRef

53.

Schwingshackl L, Chaimani A, Hoffmann G et al (2018) A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol 33:157–170PubMedPubMedCentralCrossRef

54.

Schwingshackl L, Hoffmann G, Iqbal K et al (2018) Food groups and intermediate disease markers: a systematic review and network meta-analysis of randomized trials. Am J Clin Nutr 108:576–586PubMedPubMedCentralCrossRef

55.

Neuenschwander M, Ballon A, Weber KS et al (2019) Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366:l2368PubMedPubMedCentralCrossRef

56.

Ge L, Sadeghirad B, Ball GDC et al (2020) Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ 369:m696PubMedPubMedCentralCrossRef

57.

Goldenberg JZ, Day A, Brinkworth GD et al (2021) Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 372:m4743PubMedPubMedCentralCrossRef

58.

Schwingshackl L, Nitschke K, Zähringer J et al (2020) Impact of meal frequency on anthropometric outcomes: a systematic review and network meta-analysis of randomized controlled trials. Adv Nutr 11:1108–1122PubMedPubMedCentralCrossRef

59.

Corte DKW, Perrar I, Penczynski KJ et al (2018) Effect of dietary sugar intake on biomarkers of subclinical inflammation: a systematic review and meta-analysis of intervention studies. Nutrients 10:606PubMedPubMedCentralCrossRef

60.

Schwingshackl L, Chaimani A, Schwedhelm C et al (2019) Comparative effects of different dietary approaches on blood pressure in hypertensive and pre-hypertensive patients: a systematic review and network meta-analysis. Crit Rev Food Sci Nutr 59:2674–2687PubMedCrossRef

61.

Thom G, Messow CM, Leslie WS et al (2020) Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med 38:e14395PubMedCrossRef

62.

de Souza RJ, Mente A, Maroleanu A et al (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 351:h3978PubMedPubMedCentralCrossRef

63.

Astrup A, Magkos F, Bier DM et al (2020) Saturated Fats and Health: a reassessment and proposal for food-based recommendations: JACC state-of-the-art review. J Am Coll Cardiol 76:844–857PubMedCrossRef

64.

Pimpin L, Wu JHY, Haskelberg H et al (2016) Is butter back? A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, and total mortality. PLoS ONE 11:e158118PubMedPubMedCentralCrossRef

65.

Benatar JR, Sidhu K, Stewart RAH (2013) Effects of high and low fat dairy food on cardio-metabolic risk factors: a meta-analysis of randomized studies. PLoS One 8:e76480PubMedPubMedCentralCrossRef

66.

Hooper L, Abdelhamid AS, Jimoh OF et al (2020) Effects of total fat intake on body fatness in adults. Cochrane Database Syst Rev 6:CD13636PubMed

67.

Hooper L, Martin N, Jimoh OF et al (2020) Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev 8:CD11737PubMed

68.

Belalcazar LM, Haffner SM, Lang W et al (2013) Lifestyle intervention and/or statins for the reduction of C‑reactive protein in type 2 diabetes: from the look AHEAD study. Obesity 21:944–950PubMedCrossRef

69.

Belalcazar LM, Reboussin DM, Haffner SM et al (2010) A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C‑reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33:2297–2303PubMedPubMedCentralCrossRef

70.

Lu M, Wan Y, Yang B et al (2018) Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and metaanalysis of randomised controlled trials. Br J Nutr 119:96–108PubMedCrossRef

71.

Wu JHY, Marklund M, Imamura F et al (2017) Omega‑6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol 5:965–974PubMedPubMedCentralCrossRef

72.

Li J, Guasch-Ferré M, Li Y et al (2020) Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr 112:150–167PubMedPubMedCentralCrossRef

73.

an Pan A, Chen M, Chowdhury R et al (2012) α‑Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 96:1262–1273PubMedPubMedCentralCrossRef

74.

Abdelhamid AS, Martin N, Bridges C et al (2018) Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 11:CD12345PubMed

75.

Abdelhamid AS, Brown TJ, Brainard JS et al (2020) Omega‑3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 3:CD3177PubMed

76.

Brown TJ, Brainard J, Song F et al (2019) Omega‑3, omega‑6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ 366:l4697PubMedPubMedCentralCrossRef

77.

Qian F, Korat AA, Malik V et al (2016) Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39:1448–1457PubMedPubMedCentralCrossRef

78.

Jovanovski E, de Castro Ruiz Marques A, Li D et al (2019) Effect of high-carbohydrate or high-monounsaturated fatty acid diets on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 77:19–31PubMedCrossRef

79.

Zhang YY, Liu W, Zhao TY et al (2017) Efficacy of omega‑3 polyunsaturated fatty acids supplementation in managing overweight and obesity: a meta-analysis of randomized clinical trials. J Nutr Health Aging 21:187–192PubMedCrossRef

80.

Lin N, Shi JJ, Li YM et al (2016) What is the impact of n‑3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis 15:133PubMedPubMedCentralCrossRef

81.

Reis CEG, Landim KC, Nunes ACS et al (2014) Safety in the hypertriglyceridemia treatment with N‑3 polyunsaturated fatty acids on glucose metabolism in subjects with type 2 diabetes mellitus. Nutr Hosp 31:570–576PubMed

82.

Gao L, Cao J, Mao Q et al (2013) Influence of omega‑3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 226:328–334PubMedCrossRef

83.

He XX, Wu XL, Chen RP et al (2016) Effectiveness of omega‑3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLoS ONE 11:e162368PubMedPubMedCentralCrossRef

84.

Li N, Yue H, Jia M et al (2019) Effect of low-ratio n‑6/n‑3 PUFA on blood glucose: a meta-analysis. Food Funct 10:4557–4565PubMedCrossRef

85.

Wanders AJ, Blom WAM, Zock PL et al (2019) Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials. BMJ Open Diabetes Res Care 7:e585PubMedPubMedCentralCrossRef

86.

Abbott KA, Burrows TL, Thota RN et al (2016) Do ω‑3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 104:1470–1484PubMedCrossRef

87.

Jovanovski E, Li D, Thanh Ho HV et al (2017) The effect of alpha-linolenic acid on glycemic control in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized controlled clinical trials. Medicine 96:e6531PubMedPubMedCentralCrossRef

88.

Faris MAI, Jahrami H, BaHammam A et al (2020) A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects. Diabetes Res Clin Pract 165:108226PubMedCrossRef

89.

Mirmiran P, Bahadoran Z, Gaeini Z et al (2019) Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: an updated meta-analysis. Nutr Metab Cardiovasc Dis 29:906–915PubMedCrossRef

90.

Fernando HA, Zibellini J, Harris RA et al (2019) Effect of ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients 11:478PubMedPubMedCentralCrossRef

91.

Horne BD, May HT, Anderson JL et al (2008) Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102:814–819PubMedPubMedCentralCrossRef

92.

Horne BD, Muhlestein JB, May HT et al (2012) Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 109:1558–1562PubMedCrossRef

93.

Schwingshackl L, Zähringer J, Nitschke K et al (2021) Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses. Crit Rev Food Sci Nutr 61:1293–1304PubMedCrossRef

94.

Park J, Seo YG, Paek YJ et al (2020) Effect of alternate-day fasting on obesity and cardiometabolic risk: a systematic review and meta-analysis. Metabolism 111:154336PubMedCrossRef

95.

Harris L, Hamilton S, Azevedo LB et al (2018) Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep 16:507–547PubMedCrossRef

96.

Seimon RV, Roekenes JA, Zibellini J et al (2015) Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Mol Cell Endocrinol 418:153–172PubMedCrossRef

97.

Horne BD, Muhlestein JB, Anderson JL (2015) Health effects of intermittent fasting: hormesis or harm? A systematic review. Am J Clin Nutr 102:464–470PubMedCrossRef

98.

Borgundvaag E, Mak J, Kramer CK (2021) Metabolic impact of intermittent fasting in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of interventional studies. J Clin Endocrinol Metab 106:902–911PubMedCrossRef

99.

Parr EB, Devlin BL, Lim KHC et al (2020) Time-restricted eating as a nutrition strategy for individuals with type 2 diabetes: a feasibility study. Nutrients 12:3228PubMedPubMedCentralCrossRef

100.

Carter S, Clifton PM, Keogh JB (2016) The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 122:106–112PubMedCrossRef

101.

Carter S, Clifton PM, Keogh JB (2019) The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract 151:11–19PubMedCrossRef

102.

Corley BT, Carroll RW, Hall RM et al (2018) Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med 35:588–594PubMedCrossRef

103.

Henry RR, Wiest-Kent TA, Scheaffer L et al (1986) Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 35:155–164PubMedCrossRef

104.

Amatruda JM, Richeson JF, Welle SL et al (1988) The safety and efficacy of a controlled low-energy (“very-low-calorie”) diet in the treatment of noninsulin-dependent diabetes and obesity. Arch Intern Med 148:873–877PubMedCrossRef

105.

Rotella CM, Cresci B, Mannucci E et al (1994) Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus. J Endocrinol Invest 17:171–179PubMedCrossRef

106.

Dhindsa P, Scott AR, Donnelly R (2003) Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med 20:319–324PubMedCrossRef

107.

American Diabetes Association (2022) Standards of medical care in diabetes. Clin Diabetes 2022(40):10–38CrossRef

108.

Lean MEJ, Leslie WS, Barnes AC et al (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2‑year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 7:344–355PubMedCrossRef

109.

Colditz GA, Willett WC, Rotnitzky A et al (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486PubMedCrossRef

110.

Leslie WS, Taylor R, Harris L et al (2017) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes 41:96–101CrossRef

111.

McCombie L, Brosnahan N, Ross H et al (2019) Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity. J Hum Nutr Diet 32:329–337PubMedCrossRef

112.

Jazet IM, de Craen AJ, van Schie EM et al (2007) Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res Clin Pract 77:70–76PubMedCrossRef

113.

Kempf K, Schloot NC, Gärtner B et al (2014) Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with 100 U insulin per day. J Hum Nutr Diet 27(Suppl. 02):21–27PubMedCrossRef

114.

Kempf K, Röhling M, Niedermeier K et al (2018) Individualized meal replacement therapy improves clinically relevant long-term glycemic control in poorly controlled type 2 diabetes patients. Nutrients 10:1022PubMedPubMedCentralCrossRef

115.

Taylor R, Leslie WS, Barnes AC et al (2018) Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia 61:589–598PubMedCrossRef

116.

Halle M, Röhling M, Banzer W et al (2021) Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors—the ACOORH trial. Eur J Clin Nutr 75:661–669PubMedCrossRef

117.

Röhling M, Kempf K, Banzer W et al (2020) Prediabetes conversion to normoglycemia is superior adding a low-carbohydrate and energy deficit formula diet to lifestyle intervention‑A 12-month subanalysis of the ACOORH trial. Nutrients 12:2022PubMedPubMedCentralCrossRef

118.

Rosenfeld RM, Kelly JH, Agarwal M et al (2022) Dietary intervention to treat T2DM in adults with a goal of remission: an expert consensus statement from the American College of Lifestyle Medcine. Am J Lifestyle Med 16:342–362PubMedPubMedCentralCrossRef

119.

Holman RR, Paul SK, Bethel MA et al (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef

120.

Haslacher H, Fallmann H, Waldhäusl C et al (2019) Type 2 diabetes care: Improvement by standardization at a diabetes rehabilitation clinic. An observational report. PLoS ONE 14:e226132PubMedPubMedCentralCrossRef

121.

Paul SK, Shaw JE, Montvida O et al (2016) Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes. Diabetes Obes Metab 18:1244–1252PubMedCrossRef

122.

American Diabetes Association (2020) 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes—2020. Diabetes Care 43:48–S65CrossRef

123.

Dyson PA, Twenefour D, Breen C et al (2018) Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 35:541–547PubMedCrossRef

124.

Dworatzek PD, Arcudi K, Gougeon R et al (2013) Nutrition therapy. Can J Diabetes 37(Suppl. 01):S45–S55PubMedCrossRef

125.

Hallberg SJ, Dockter NE, Kushner JA et al (2019) Improving the scientific rigour of nutritional recommendations for adults with type 2 diabetes: a comprehensive review of the American Diabetes Association guideline-recommended eating patterns. Diabetes Obes Metab 21:1769–1779PubMedPubMedCentralCrossRef

126.

Salas-Salvadó J, Becerra-Tomás N, Papandreou C et al (2019) Dietary patterns emphasizing the consumption of plant foods in the management of type 2 diabetes: a narrative review. Adv Nutr 10:S320–S331PubMedPubMedCentralCrossRef

127.

Viguiliouk E, Kendall CW, Kahleová H et al (2019) Effect of vegetarian dietary patterns on cardiometabolic risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 38:1133–1145PubMedCrossRef

128.

Papamichou D, Panagiotakos DB, Itsiopoulos C (2019) Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis 29:531–543PubMedCrossRef

129.

Ohlsson B (2019) An Okinawan-based Nordic diet improves glucose and lipid metabolism in health and type 2 diabetes, in alignment with changes in the endocrine profile, whereas zonulin levels are elevated. Exp Ther Med 17:2883–2893PubMedPubMedCentral

130.

Daneshzad E, Emami S, Darooghegi Mofrad M et al (2018) Association of modified Nordic diet with cardiovascular risk factors among type 2 diabetes patients: a cross-sectional study. J Cardiovasc Thorac Res 10:153–161PubMedPubMedCentralCrossRef

131.

Via MA, Mechanick JI (2016) Nutrition in type 2 diabetes and the metabolic syndrome. Med Clin North Am 100:1285–1302PubMedCrossRef

132.

Garvey WT, Mechanick JI, Brett EM et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive CLINICAL practice guidelines for medical care of patients with obesity. Endocr Pract 22(Suppl. 03):1–203PubMedCrossRef

133.

Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97:505–516PubMedCrossRef

134.

Huo R, Du T, Xu Y et al (2015) Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr 69:1200–1208PubMedCrossRef

135.

Pan B, Wu Y, Yang Q et al (2019) The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: a network meta-analysis. J Evid Based Med 12:29–39PubMedCrossRef

136.

Johannesen CO, Dale HF, Jensen C et al (2020) Effects of plant-based diets on outcomes related to glucose metabolism: a systematic review. Diabetes Metab Syndr Obes 13:2811–2822PubMedPubMedCentralCrossRef

137.

Toumpanakis A, Turnbull T, Alba-Barba I (2018) Effectiveness of plant-based diets in promoting well-being in the management of type 2 diabetes: a systematic review. BMJ Open Diabetes Res Care 6:e534PubMedPubMedCentralCrossRef

138.

Tran E, Dale HF, Jensen C et al (2020) Effects of plant-based diets on weight status: a systematic review. Diabetes Metab Syndr Obes 13:3433–3448PubMedPubMedCentralCrossRef

139.

Austin G, Ferguson J, Garg M et al (2021) Effects of plant-based diets on weight status in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Nutrients 13:4099PubMedPubMedCentralCrossRef

140.

Esposito K, Maiorino MI, Bellastella G et al (2015) A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open 5:e8222PubMedPubMedCentralCrossRef

141.

Carter P, Achana F, Troughton J et al (2014) A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis. J Hum Nutr Diet 27:280–297PubMedCrossRef

142.

Emadian A, Andrews RC, England CY et al (2015) The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. Br J Nutr 114:1656–1666PubMedPubMedCentralCrossRef

143.

Kahleova H, Salas-Salvadó J, Rahelić D et al (2019) Dietary patterns and cardiometabolic outcomes in diabetes: a summary of systematic reviews and meta-analyses. Nutrients 11:2209PubMedPubMedCentralCrossRef

144.

Deutsche Diabetes Gesellschaft (DDG). https://www.deutsche-diabetes-gesellschaft.de/fileadmin/user_upload/01_Die_DDG/03_Ausschuesse/02_Ernaehrung/2015-057-025l_S3_Diabetes_mellitus_Empfehlungen_Proteinzufuhr_2015-10.pdf

145.

Pfeiffer AFH, Pedersen E, Schwab U et al (2020) The effects of different quantities and qualities of protein intake in people with diabetes mellitus. Nutrients 12:365PubMedPubMedCentralCrossRef

146.

Mittendorfer B, Klein S, Fontana L (2020) A word of caution against excessive protein intake. Nat Rev Endocrinol 16:59–66PubMedCrossRef

147.

Labonte CC, Chevalier S, Marliss EB et al (2015) Effect of 10 % dietary protein intake on whole body protein kinetics in type 2 diabetic adults. Clin Nutr 34:1115–1121PubMedCrossRef

148.

Markova M, Hornemann S, Sucher S et al (2018) Rate of appearance of amino acids after a meal regulates insulin and glucagon secretion in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 108:279–291PubMedCrossRef

149.

Volkert D (2020) Aktuelle ESPEN-Leitlinie Klinische Ernährung und Hydration in der Geriatrie. Dtsch Med Wochenschr 145:1306–1314PubMedCrossRef

150.

Song M, Fung TT, Hu FB et al (2016) Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med 176:1453–1463PubMedPubMedCentralCrossRef

151.

Ye J, Yu Q, Mai W et al (2019) Dietary protein intake and subsequent risk of type 2 diabetes: a dose-response meta-analysis of prospective cohort studies. Acta Diabetol 56:851–870PubMedCrossRef

152.

Vernooij RWM, Zeraatkar D, Han MA et al (2019) Patterns of red and processed meat consumption and risk for cardiometabolic and cancer outcomes: a systematic review and meta-analysis of cohort studies. Ann Intern Med 171:732–741PubMedCrossRef

153.

Vogtschmidt YD, Raben A, Faber I et al (2021) Is protein the forgotten ingredient: effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 328:124–135PubMedCrossRef

154.

Clifton PM, Condo D, Keogh JB (2014) Long term weight maintenance after advice to consume low carbohydrate, higher protein diets—a systematic review and meta analysis. Nutr Metab Cardiovasc Dis 24:224–235PubMedCrossRef

155.

Hahn D, Hodson EM, Fouque D (2020) Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev 10:CD1892PubMed

156.

Ikizler TA, Burrowes JD, Byham-Gray LD et al (2020) KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 76:S1–S107PubMedCrossRef

157.

Menon V, Kopple JD, Wang X et al (2009) Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53:208–217PubMedCrossRef

158.

Jiang Z, Tang Y, Yang L et al (2018) Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 50:687–694PubMedCrossRef

159.

Fiaccadori E, Sabatino A, Barazzoni R et al (2021) ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease. Clin Nutr 40:1644–1668PubMedCrossRef

160.

Dong JY, Zhang ZL, Wang PY et al (2013) Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Br J Nutr 110:781–789PubMedCrossRef

161.

Anonymous (1998) Carbohydrates in human nutrition. Report of a joint FAO/WHO expert consultation. Fao Food Nutr Pap 66:1–140

162.

Wolever TMS (2016) Personalized nutrition by prediction of glycaemic responses: fact or fantasy? Eur J Clin Nutr 70:411–413PubMedCrossRef

163.

Berry SE, Valdes AM, Drew DA et al (2020) Human postprandial responses to food and potential for precision nutrition. Nat Med 26:964–973PubMedPubMedCentralCrossRef

164.

Zeevi D, Korem T, Zmora N et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094PubMedCrossRef

165.

Livesey G, Taylor R, Livesey H et al (2013) Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies. Am J Clin Nutr 97:584–596PubMedPubMedCentralCrossRef

166.

Livesey G, Livesey H (2019) Coronary heart disease and dietary carbohydrate, glycemic index, and glycemic load: dose-response meta-analyses of prospective cohort studies. Mayo Clin Proc Innov Qual Outcomes 3:52–69PubMedPubMedCentralCrossRef

167.

Thomas DE, Elliott EJ (2010) The use of low-glycaemic index diets in diabetes control. Br J Nutr 104:797–802PubMedCrossRef

168.

Xu B, Fu J, Qiao Y et al (2021) Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with type 2 diabetes. Am J Clin Nutr 113:1515–1530PubMedCrossRef

169.

Jenkins DJA, Kendall CWC, McKeown-Eyssen G et al (2008) Effect of a low glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 300:2742–2753PubMedCrossRef

170.

Holub I, Gostner A, Hessdörfer S et al (2009) Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus. Horm Metab Res 41:886–892PubMedCrossRef

171.

Brand-Miller J, Hayne S, Petocz P et al (2003) Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 26:2261–2267PubMedCrossRef

172.

Ojo O, Ojo OO, Adebowale F et al (2018) The effect of dietary glycaemic index on glycaemia in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients 10:373PubMedPubMedCentralCrossRef

173.

Franz MJ, MacLeod J, Evert A et al (2017) Academy of nutrition and dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet 117:1659–1679PubMedCrossRef

174.

Vega-López S, Venn BJ, Slavin JL (2018) Relevance of the glycemic index and Glycemic load for body weight, diabetes, and cardiovascular disease. Nutrients 10:1361PubMedPubMedCentralCrossRef

175.

Jenkins DJA, Dehghan M, Mente A et al (2021) Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med 384:1312–1322PubMedCrossRef

176.

Coutinho M, Gerstein HC, Wang Y et al (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMedCrossRef

177.

Levitan EB, Song Y, Ford ES et al (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef

178.

Siri PW, Krauss RM (2005) Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 7:455–459PubMedCrossRef

179.

Aune D, Norat T, Romundstad P et al (2013) Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol 28:845–858PubMedCrossRef

180.

InterAct Consortium (2015) Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-interact study and a meta-analysis of prospective studies. Diabetologia 58:1394–1408CrossRef

181.

Kim Y, Je Y (2016) Dietary fibre intake and mortality from cardiovascular disease and all cancers: a meta-analysis of prospective cohort studies. Arch Cardiovasc Dis 109:39–54PubMedCrossRef

182.

Reynolds AN, Akerman AP, Mann J (2020) Dietary fibre and whole grains in diabetes management: systematic review and meta-analyses. PLoS Med 17:e1003053PubMedPubMedCentralCrossRef

183.

Da Silva Borges D, Fernandes R, Thives Mello A et al (2020) Prebiotics may reduce serum concentrations of C‑reactive protein and ghrelin in overweight and obese adults: a systematic review and meta-analysis. Nutr Rev 78:235–248PubMed

184.

Reynolds A, Mann J, Cummings J et al (2019) Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393:434–445PubMedCrossRef

185.

Musa-Veloso K, Poon T, Harkness LS et al (2018) The effects of whole-grain compared with refined wheat, rice, and rye on the postprandial blood glucose response: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 108:759–774PubMedCrossRef

186.

Wang W, Li J, Chen X et al (2020) Whole grain food diet slightly reduces cardiovascular risks in obese/overweight adults: a systematic review and meta-analysis. BMC Cardiovasc Disord 20:82PubMedPubMedCentralCrossRef

187.

Weickert MO, Roden M, Isken F et al (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94:459–471PubMedCrossRef

188.

Honsek C, Kabisch S, Kemper M et al (2018) Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia 61:1295–1305PubMedCrossRef

189.

Kabisch S, Meyer NMT, Honsek C et al (2019) Fasting glucose state determines metabolic response to supplementation with insoluble cereal fibre: a secondary analysis of the Optimal Fibre Trial (OptiFiT). Nutrients 11:2385PubMedPubMedCentralCrossRef

190.

Hjorth MF, Ritz C, Blaak EE et al (2017) Pretreatment fasting plasma glucose and insulin modify dietary weight loss success: results from 3 randomized clinical trials. Am J Clin Nutr 106:499–505PubMedCrossRef

191.

Xiao Z, Chen H, Zhang Y et al (2020) The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: a systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res 34:1237–1247PubMedCrossRef

192.

Wang L, Yang H, Huang H et al (2019) Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and doseresponse meta-analysis of 33 randomized controlled trials. J Transl Med 17:410PubMedPubMedCentralCrossRef

193.

Rao M, Gao C, Xu L et al (2019) Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis. J Diabetes Res: 5101423

194.

Darooghegi Mofrad M, Mozaffari H, Mousavi SM et al (2020) The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: a systematic review and dose-response metaanalysis of randomized controlled trials. Crit Rev Food Sci Nutr 60:859–872PubMedCrossRef

195.

Rahmani J, Miri A, Černevičiūtė R et al (2019) Effects of cereal beta-glucan consumption on body weight, body mass index, waist circumference and total energy intake: a meta-analysis of randomized controlled trials. Complement Ther Med 43:131–139PubMedCrossRef

196.

Ho HVT, Sievenpiper JL, Zurbau A et al (2016) The effect of oat β‑glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 116:1369–1382PubMedCrossRef

197.

Jovanovski E, Yashpal S, Komishon A et al (2018) Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 108:922–932PubMedCrossRef

198.

Brum J, Ramsey D, McRorie J et al (2018) meta-analysis of usefulness of psyllium fiber as adjuvant antilipid therapy to enhance cholesterol lowering efficacy of statins. Am J Cardiol 122:1169–1174PubMedCrossRef

199.

Ho HVT, Jovanovski E, Zurbau A et al (2017) A systematic review and metaanalysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B. Am J Clin Nutr 105:1239–1247PubMedCrossRef

200.

Pittler MH, Ernst E (2001) Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 110:724–730PubMedCrossRef

201.

Khan K, Jovanovski E, Ho HVT et al (2018) The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 28:3–13PubMedCrossRef

202.

Thinggaard M, Jacobsen R, Jeune B et al (2010) Is the relationship between BMI and mortality increasingly U‑shaped with advancing age? A 10-year follow-up of persons aged 70–95 years. J Gerontol A Biol Sci Med Sci 65:526–531PubMedCrossRef

203.

Guigoz Y, Vellas B (1997) Malnutrition in the elderly: the Mini Nutritional Assessment (MNA). Ther Umsch 54:345–350PubMed

204.

Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 56:M366–M372PubMedCrossRef

205.

Bahrmann A, Bahrmann P, Baumann J et al (2018) S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Diabetol Stoffwechs 13:423–489 (2. Auflage 2018 – AWMF-Register-Nr. 057-017)CrossRef

206.

Volkert D, Bauer J, Frühwald T et al (2013) S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGG Klinische Ernährung in der Geriatrie. Aktuel Ernahrungsmed 38:e1–e48CrossRef

207.

Zeyfang A, Wernecke J, Bahrmann A (2020) Diabetes mellitus im Alter. Diabetol Stoffwechs 15(Suppl. 01):S112–S119

208.

Şat S, Aydınkoç-Tuzcu K, Berger F et al (2019) Diabetes und Migration. Diabetol Stoffwechs 14(Suppl. 02):S306–S317

209.

Diker O, Deniz T, Çetinkaya A (2016) History of Turkish cuisine culture and the influence of the balkans. IOSR J Humanit Soc Sci 10:1–6

210.

Schmid B (2003) Ernährung und Migration [Zugl.: München, Techn. Univ., Diss., 2003. Utz, Wiss; c, München

211.

Magni P, Bier DM, Pecorelli S et al (2017) Perspective: improving nutritional guidelines for sustainable health policies: current status and perspectives. Adv Nutr 8:532–545PubMedPubMedCentral

212.

Praxistool zur Ernährung. Orientierungshilfe für die Diabetesberatung nach geografischen Räumen. https://migration.deutsche-diabetes-gesellschaft.de/fileadmin/user_upload/01_Die_DDG/05_Arbeitsgemeinschaften/AG_Migranten/Microsite/200417_Ernaehrungstoo_DDG-GB19-Einleger_04.pdf (Erstellt: 15. Juli 2021)

213.

ElSayed NA, Aleppo G, Aroda VR et al (2023) Summary of Revisions: Standards of Care in Diabetes—2023. Diabetes Care 46(Suppl. 01):S5–S9PubMedCrossRef

214.

Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754PubMedPubMedCentralCrossRef

215.

European Commission Health promotion and disease prevention knowledge gateway: sugars and sweeteners. https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/sugars-sweeteners

216.

Committee on Nutrition (2015) Carbohydrates and Health report. https://www.gov.uk/government/publications/

217.

McKeown NM, Dashti HS, Ma J et al (2018) Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. Diabetologia 61:317–330PubMedCrossRef

218.

Imamura F, O’Connor L, Ye Z et al (2015) Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ 351:h3576PubMedPubMedCentralCrossRef

219.

Malik VS, Hu FB (2022) The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol 18:205–218PubMedPubMedCentralCrossRef

220.

Malik VS, Hu FB (2015) Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol 66:1615–1624PubMedPubMedCentralCrossRef

221.

Evans RA, Frese M, Romero J et al (2017) Chronic fructose substitution for glucose or sucrose in food or beverages has little effect on fasting blood glucose, insulin, or triglycerides: a systematic review and metaanalysis. Am J Clin Nutr 106:519–529PubMedCrossRef

222.

Evans RA, Frese M, Romero J et al (2017) Fructose replacement of glucose or sucrose in food or beverages lowers postprandial glucose and insulin without raising triglycerides: a systematic review and meta-analysis. Am J Clin Nutr 106:506–518PubMedCrossRef

223.

Keller A, Heitmann BL, Olsen N (2015) Sugar-sweetened beverages, vascular risk factors and events: a systematic literature review. Public Health Nutr 18:1145–1154PubMedCrossRef

224.

Huang C, Huang J, Tian Y et al (2014) Sugar sweetened beverages consumption and risk of coronary heart disease: a meta-analysis of prospective studies. Atherosclerosis 234:11–16PubMedCrossRef

225.

Narain A, Kwok CS, Mamas MA (2016) Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract 70:791–805PubMedCrossRef

226.

Cheungpasitporn W, Thongprayoon C, O’Corragain OA et al (2014) Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology 19:791–797PubMedCrossRef

227.

Chen H, Wang J, Li Z et al (2019) Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty liver disease: an updated systematic review and dose-response meta-analysis. Int J Environ Res Public Health 16:2192PubMedPubMedCentralCrossRef

228.

Asgari-Taee F, Zerafati-Shoae N, Dehghani M et al (2019) Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr 58:1759–1769PubMedCrossRef

229.

Khan TA, Sievenpiper JL (2016) Controversies about sugars: results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes. Eur J Nutr 55:25–43PubMedPubMedCentralCrossRef

230.

Choo VL, Viguiliouk E, Blanco Mejia S et al (2018) Food sources of fructosecontaining sugars and glycaemic control: systematic review and metaanalysis of controlled intervention studies. BMJ 363:k4644PubMedPubMedCentralCrossRef

231.

Semnani-Azad Z, Khan TA, Blanco Mejia S et al (2020) Association of major food sources of fructose-containing sugars with incident metabolic syndrome: a systematic review and meta-analysis. JAMA Netw Open 3:e209993PubMedPubMedCentralCrossRef

232.

Bechthold A (2018) Vollwertig essen und trinken nach den 10 Regeln der DGE. Deutsche Gesellschaft für Ernährung e. V. (DGE), Bonn

233.

Wu H, Flint AJ, Qi Q et al (2015) Association between dietary whole grain intake and risk of mortality: two large prospective studies in US men and women. JAMA Intern Med 175:373–384PubMedPubMedCentralCrossRef

234.

Johnsen NF, Frederiksen K, Christensen J et al (2015) Whole-grain products and whole-grain types are associated with lower all-cause and causespecific mortality in the Scandinavian HELGA cohort. Br J Nutr 114:608–623PubMedCrossRef

235.

Wei H, Gao Z, Liang R et al (2016) Whole-grain consumption and the risk of all-cause, CVD and cancer mortality: a meta-analysis of prospective cohort studies—CORRIGENDUM. Br J Nutr 116:952PubMedCrossRef

236.

Chen GC, Tong X, Xu JY et al (2016) Whole-grain intake and total, cardiovascular, and cancer mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 104:164–172PubMedCrossRef

237.

Benisi-Kohansal S, Saneei P, Salehi-Marzijarani M et al (2016) Whole-grain intake and mortality from all causes, cardiovascular disease, and cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Adv Nutr 7:1052–1065PubMedPubMedCentralCrossRef

238.

Zong G, Gao A, Hu FB et al (2016) Whole grain intake and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Circulation 133:2370–2380PubMedPubMedCentralCrossRef

239.

Aune D, Keum N, Giovannucci E et al (2016) Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ 353:i2716PubMedPubMedCentralCrossRef

240.

Aune D (2019) Plant foods, antioxidant biomarkers, and the risk of cardiovascular disease, cancer, and mortality: a review of the evidence. Adv Nutr 10:S404–S421PubMedPubMedCentralCrossRef

241.

Zhang B, Zhao Q, Guo W et al (2018) Association of whole grain intake with all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis from prospective cohort studies. Eur J Clin Nutr 72:57–65PubMedCrossRef

242.

Jenkins DJ, Wesson V, Wolever TM et al (1988) Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. BMJ 297:958–960PubMedPubMedCentralCrossRef

243.

Reynolds AN, Mann J, Elbalshy M et al (2020) Wholegrain particle size influences postprandial glycemia in type 2 diabetes: a randomized crossover study comparing four wholegrain breads. Diabetes Care 43:476–479PubMedCrossRef

244.

Åberg S, Mann J, Neumann S et al (2020) Whole-grain processing and glycemic control in type 2 diabetes: a randomized crossover trial. Diabetes Care 43:1717–1723PubMedPubMedCentralCrossRef

245.

Jenkins DJA, Kendall CWC, Augustin LSA et al (2002) Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 25:1522–1528PubMedCrossRef

246.

Miller V, Mente A, Dehghan M et al (2017) Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet 390:2037–2049PubMedCrossRef

247.

Aune D, Giovannucci E, Boffetta P et al (2017) Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 46:1029–1056PubMedPubMedCentralCrossRef

248.

Bechthold A, Boeing H, Schwedhelm C et al (2019) Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr 59:1071–1090PubMedCrossRef

249.

Zhan J, Liu YJ, Cai LB et al (2017) Fruit and vegetable consumption and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 57:1650–1663PubMedCrossRef

250.

Willett W, Rockström J, Loken B et al (2019) Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 393:447–492PubMedCrossRef

251.

Barnard ND, Cohen J, Jenkins DJA et al (2006) A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 29:1777–1783PubMedCrossRef

252.

Jenkins DJA, Kendall CWC, Augustin LSA et al (2012) Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 172:1653–1660PubMedCrossRef

253.

Renner B, Arens-Azevêdo U, Watzl B et al (2021) DGE-Positionspapier zur nachhaltigeren Ernährung. Ernährungsumschau 68:144–154

254.

Jannasch F, Kröger J, Schulze MB (2017) Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J Nutr 147:1174–1182PubMedCrossRef

255.

Wallin A, Di Giuseppe D, Orsini N et al (2012) Fish consumption, dietary longchain n‑3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 35:918–929PubMedPubMedCentralCrossRef

256.

Xun P, He K (2012) Fish Consumption and Incidence of Diabetes: meta-analysis of data from 438000 individuals in 12 independent prospective cohorts with an average 11-year follow-up. Diabetes Care 35:930–938PubMedPubMedCentralCrossRef

257.

Schwingshackl L, Hoffmann G, Lampousi AM et al (2017) Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol 32:363–375PubMedPubMedCentralCrossRef

258.

Muley A, Muley P, Shah M (2014) ALA, fatty fish or marine n‑3 fatty acids for preventing DM?: a systematic review and meta-analysis. Curr Diabetes Rev 10:158–165PubMedCrossRef

259.

Schlesinger S, Neuenschwander M, Schwedhelm C et al (2019) Food groups and risk of overweight, obesity, and weight gain: a systematic review and dose-response meta-analysis of prospective studies. Adv Nutr 10:205–218PubMedPubMedCentralCrossRef

260.

Micha R, Shulkin ML, Peñalvo JL et al (2017) Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS ONE 12:e175149PubMedPubMedCentralCrossRef

261.

Jayedi A, Shab-Bidar S, Eimeri S et al (2018) Fish consumption and risk of all-cause and cardiovascular mortality: a dose-response meta-analysis of prospective observational studies. Public Health Nutr 21:1297–1306PubMedPubMedCentralCrossRef

262.

Abdelhamid AS, Brown TJ, Brainard JS et al (2018) Omega‑3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 11:CD3177PubMed

263.

Hu Y, Hu FB, Manson JE (2019) Marine omega‑3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc 8:e13543PubMedPubMedCentralCrossRef

264.

Gao H, Geng T, Huang T et al (2017) Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis 16:131PubMedPubMedCentralCrossRef

265.

Chen C, Yu X, Shao S (2015) Effects of omega‑3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: a meta-analysis. PLoS ONE 10:e139565PubMedPubMedCentralCrossRef

266.

DGE – Deutsche Gesellschaft für Ernährung. Vollwertig essen und trinken nach den 10 Regeln der DGE. https://www.dge.de/ernaehrungspraxis/vollwertige-ernaehrung/10-regelnder-dge/

267.

Zeraatkar D, Han MA, Guyatt GH et al (2019) Red and processed meat consumption and risk for all-cause mortality and cardiometabolic outcomes: a systematic review and meta-analysis of cohort studies. Ann Intern Med 171:703–710PubMedCrossRef

268.

Davidson MH, Hunninghake D, Maki KC et al (1999) Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among freeliving persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med 159:1331–1338PubMedCrossRef

269.

Hunninghake DB, Maki KC, Kwiterovich PO et al (2000) Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia. J Am Coll Nutr 19:351–360PubMedCrossRef

270.

Bergeron N, Chiu S, Williams PT et al (2019) Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial. Am J Clin Nutr 110:24–33PubMedPubMedCentralCrossRef

271.

Charlton K, Walton K, Batterham M et al (2016) Pork and chicken meals similarly impact on cognitive function and strength in community-living older adults: a pilot study. J Nutr Gerontol Geriatr 35:124–145PubMedCrossRef

272.

Murphy KJ, Parker B, Dyer KA et al (2014) A comparison of regular consumption of fresh lean pork, beef and chicken on body composition: a randomized cross-over trial. Nutrients 6:682–696PubMedPubMedCentralCrossRef

273.

Murphy KJ, Thomson RL, Coates AM et al (2012) Effects of eating fresh lean pork on cardiometabolic health parameters. Nutrients 4:711–723PubMedPubMedCentralCrossRef

274.

Johnston BC, Zeraatkar D, Han MA et al (2019) Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the nutritional recommendations (NutriRECS) consortium. Ann Intern Med 171:756–764PubMedCrossRef

275.

Davis PA, Yokoyama W (2011) Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food 14:884–889PubMedCrossRef

276.

Akilen R, Tsiami A, Devendra D et al (2012) Cinnamon in glycaemic control: systematic review and meta analysis. Clin Nutr 31:609–615PubMedCrossRef

277.

Leach MJ, Kumar S (2012) Cinnamon for diabetes mellitus. Cochrane Database Syst Rev: CD7170

278.

Allen RW, Schwartzman E, Baker WL et al (2013) Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11:452–459PubMedPubMedCentralCrossRef

279.

Costello RB, Dwyer JT, Saldanha L et al (2016) Do cinnamon supplements have a role in glycemic control in type 2 diabetes? A narrative review. J Acad Nutr Diet 116:1794–1802PubMedPubMedCentralCrossRef

280.

Sierra-Puente D, Abadi-Alfie S, Arakanchi-Altaled K et al (2019) Cinammon (Cinnamomum Spp.) and type 2 diabetes mellitus. CTNR 18:247–255CrossRef

281.

Chan CB, Hashemi Z, Subhan FB (2017) The impact of low and no-caloric sweeteners on glucose absorption, incretin secretion, and glucose tolerance. Appl Physiol Nutr Metab 42:793–801PubMedCrossRef

282.

Brown AW, Bohan Brown MM, Onken KL et al (2011) Short-term consumption of sucralose, a nonnutritive sweetener, is similar to water with regard to select markers of hunger signaling and short-term glucose homeostasis in women. Nutr Res 31:882–888PubMedCrossRef

283.

Ford HE, Peters V, Martin NM et al (2011) Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects. Eur J Clin Nutr 65:508–513PubMedCrossRef

284.

Steinert RE, Frey F, Töpfer A et al (2011) Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr 105:1320–1328PubMedCrossRef

285.

Barriocanal LA, Palacios M, Benitez G et al (2008) Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol 51:37–41PubMedCrossRef

286.

Brown RJ, Walter M, Rother KI (2012) Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care 35:959–964PubMedPubMedCentralCrossRef

287.

Grotz VL, Henry RR, McGill JB et al (2003) Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 103:1607–1612PubMedCrossRef

288.

Maki KC, Curry LL, Reeves MS et al (2008) Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 46(Suppl. 07):S47–S53PubMedCrossRef

289.

Olalde-Mendoza L, Moreno-González YE (2013) Modificación de la glucemia en ayuno en adultos con diabetes mellitus tipo 2 después de la ingesta de refrescos de cola y de dieta en el estado de querétaro, México. Arch Latinoam Nutr 63:142–147PubMed

290.

Temizkan S, Deyneli O, Yasar M et al (2015) Sucralose enhances GLP‑1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes. Eur J Clin Nutr 69:162–166PubMedCrossRef

291.

Ferrazzano GF, Cantile T, Alcidi B et al (2015) Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A review. Molecules 21:E38PubMedCrossRef

292.

Prashant GM, Patil RB, Nagaraj T et al (2012) The antimicrobial activity of the three commercially available intense sweeteners against common periodontal pathogens: an in vitro study. J Contemp Dent Pract 13:749–752PubMedCrossRef

293.

Suez J, Korem T, Zeevi D et al (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514:181–186PubMedCrossRef

294.

EFSA (2013) EFSA schließt vollständige Risikobewertung zu Aspartam ab und kommt zu dem Schluss, dass es in den derzeitigen Expositionsmengen sicher ist. https://www.efsa.europa.eu/de/press/news/131210 (Erstellt: 1. Sept. 2020)

295.

Bundesinstitut für Risikobewertung Bewertung von Süßstoffen und Zuckeraustauschstoffen. Hintergrundinformation Nr. 025/2014 des BfR vom 1. www.bfr.bund.de/cm/343/bewertung_von_suessstoffen.pdf (Erstellt: 1. Sept. 2020)

296.

Bock PM, Telo GH, Ramalho R et al (2021) The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 64:26–41PubMedCrossRef

297.

Rittiphairoj T, Pongpirul K, Janchot K et al (2021) Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Adv Nutr 12:722–734PubMedCrossRef

298.

Tao YW, Gu YL, Mao XQ et al (2020) Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med 18:30PubMedPubMedCentralCrossRef

299.

Ardeshirlarijani E, Tabatabaei-Malazy O, Mohseni S et al (2019) Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials. Daru 27:827–837PubMedPubMedCentralCrossRef

300.

Mahboobi S, Rahimi F, Jafarnejad S (2018) Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: a meta-analysis of randomized controlled trials. Adv Pharm Bull 8:565–574PubMedPubMedCentralCrossRef

301.

Akbari V, Hendijani F (2016) Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev 74:774–784PubMedCrossRef

302.

Yao K, Zeng L, He Q et al (2017) Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monit 23:3044–3053PubMedPubMedCentralCrossRef

303.

Wang C, Zhang C, Li S et al (2020) Effects of probiotic supplementation on dyslipidemia in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Foods 9:1540PubMedPubMedCentralCrossRef

304.

Kasińska MA, Drzewoski J (2015) Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn 125:803–813PubMed

305.

Palacios T, Vitetta L, Coulson S et al (2020) Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: a randomised controlled pilot study. Nutrients 12:2041PubMedPubMedCentralCrossRef

306.

Zheng M, Zhang R, Tian X et al (2017) Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Front Microbiol 8:908PubMedPubMedCentralCrossRef

307.

Wong A, Ngu DYS, Dan LA et al (2015) Detection of antibiotic resistance in probiotics of dietary supplements. Nutr J 14:95PubMedPubMedCentralCrossRef

308.

BgVV – ehemals: Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin. Abschlussbericht der Arbeitsgruppe „Probiotische Mikroorganismenkulturen in Lebensmitteln“ am BgVV. https://mobil.bfr.bund.de/cm/343/probiot.pdf (Erstellt: 13. Juli 2021)

309.

de Vrese M (2008) Mikrobiologie, Wirkung und Sicherheit von Probiotika. Monatsschr Kinderheilkd 156:1063–1069CrossRef

310.

Vrieze A, van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:913–916.e7PubMedCrossRef

311.

Simon MC, Strassburger K, Nowotny B et al (2015) Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 38:1827–1834PubMedCrossRef

312.

Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63:1513–1521PubMedCrossRef

313.

Kjems LL, Holst JJ, Vølund A et al (2003) The influence of GLP‑1 on glucosestimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380–386PubMedCrossRef

314.

Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103PubMedCrossRef

315.

Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60PubMedCrossRef

316.

Larsen N, Vogensen FK, van den Berg FWJ et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085PubMedPubMedCentralCrossRef

317.

Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858PubMedCrossRef

318.

Forslund K, Hildebrand F, Nielsen T et al (2017) Corrigendum: disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 545:116PubMedCrossRef

319.

Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266PubMedPubMedCentralCrossRef

320.

Caesar R (2019) Pharmacologic and nonpharmacologic therapies for the gut microbiota in type 2 diabetes. Can J Diabetes 43:224–231PubMedCrossRef

321.

Evert AB, Boucher JL, Cypress M et al (2014) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37(Suppl. 01):S120–S143PubMedCrossRef

322.

Sievenpiper JL, Chan CB, Dworatzek PD et al (2018) Nutrition therapy. Can J Diabetes 42(Suppl. 01):S64–S79PubMedCrossRef

323.

Sievenpiper JL, de Souza RJ, Mirrahimi A et al (2012) Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 156:291–304PubMedCrossRef

324.

Ha V, Sievenpiper JL, de Souza RJ et al (2012) Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 59:787–795PubMedCrossRef

325.

Chiavaroli L, de Souza RJ, Ha V et al (2015) Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc 4:e1700PubMedPubMedCentralCrossRef

326.

Wang X, Ouyang Y, Liu J et al (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349:g4490PubMedPubMedCentralCrossRef

327.

Chiu S, Sievenpiper JL, de Souza RJ et al (2014) Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and metaanalysis of controlled feeding trials. Eur J Clin Nutr 68:416–423PubMedPubMedCentralCrossRef

328.

Wang DD, Sievenpiper JL, de Souza RJ et al (2012) The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 142:916–923PubMedPubMedCentralCrossRef

329.

Cozma AI, Sievenpiper JL, de Souza RJ et al (2012) Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care 35:1611–1620PubMedPubMedCentralCrossRef

330.

Sievenpiper JL, Chiavaroli L, de Souza RJ et al (2012) “Catalytic” doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr 108:418–423PubMedPubMedCentralCrossRef

331.

Sievenpiper JL, Carleton AJ, Chatha S et al (2009) Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 32:1930–1937PubMedPubMedCentralCrossRef

332.

Chung M, Ma J, Patel K et al (2014) Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 100:833–849PubMedPubMedCentralCrossRef

333.

Goran MI, Ulijaszek SJ, Ventura EE (2013) High fructose corn syrup and diabetes prevalence: a global perspective. Glob Public Health 8:55–64PubMedCrossRef

334.

Tsilas CS, de Souza RJ, Mejia SB et al (2017) Relation of total sugars, fructose and sucrose with incident type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. CMAJ 189:E711–E720PubMedPubMedCentralCrossRef

335.

Wang DD, Sievenpiper JL, de Souza RJ et al (2014) Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 232:125–133CrossRef

336.

Zhang YH, An T, Zhang RC et al (2013) Very high fructose intake increases serum LDL-cholesterol and total cholesterol: a meta-analysis of controlled feeding trials. J Nutr 143:1391–1398PubMedCrossRef

337.

Schwingshackl L, Neuenschwander M, Hoffmann G et al (2020) Dietary sugars and cardiometabolic risk factors: a network meta-analysis on isocaloric substitution interventions. Am J Clin Nutr 111:187–196PubMedCrossRef

338.

Weber KS, Simon MC, Strassburger K et al (2018) Habitual fructose intake relates to insulin sensitivity and fatty liver index in recent-onset type 2 diabetes patients and individuals without diabetes. Nutrients 10:774PubMedPubMedCentralCrossRef

339.

ter Horst KW, Schene MR, Holman R et al (2016) Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr 104:1562–1576PubMedCrossRef

340.

Kulzer B, Albus C, Herpertz S et al (2019) Psychosoziales und Diabetes. Diabetologie 15:452–469CrossRef

341.

Ahmed AT, Karter AJ, Warton EM et al (2008) The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 23:275–282PubMedPubMedCentralCrossRef

342.

Bantle AE, Thomas W, Bantle JP (2008) Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism 57:241–245PubMedPubMedCentralCrossRef

343.

Avogaro A, Beltramello P, Gnudi L et al (1993) Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids. Diabetes 42:1626–1634PubMedCrossRef

344.

Turner BC, Jenkins E, Kerr D et al (2001) The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 24:1888–1893PubMedCrossRef

345.

Richardson T, Weiss M, Thomas P et al (2005) Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 28:1801–1802PubMedCrossRef

346.

Pedersen-Bjergaard U, Reubsaet JLE, Nielsen SL et al (2005) Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: analysis of 141 cases. Am J Med 118:307–310PubMedCrossRef

347.

Frier B, Fisher M (Hrsg) (2007) Moderators, monitoring and management of hypoglycaemia [101–120. John Wiley & Sons, Chichester

348.

Ahmed AT, Karter AJ, Liu J (2006) Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med 23:795–802PubMedPubMedCentralCrossRef

349.

Nahas R, Goguen J (2013) Natural health products. Can J Diabetes 37(Suppl. 01):S97–S99PubMedCrossRef

350.

Hartweg J, Perera R, Montori V et al (2008) Omega‑3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD3205

351.

Hartweg J, Farmer AJ, Holman RR et al (2009) Potenzial impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 20:30–38PubMedCrossRef

352.

O’Mahoney LL, Matu J, Price OJ et al (2018) Omega‑3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 17:98PubMedPubMedCentralCrossRef

353.

Mirhosseini N, Vatanparast H, Mazidi M et al (2017) The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: a meta-analysis. J Clin Endocrinol Metab 102:3097–3110PubMedCrossRef

354.

Li X, Liu Y, Zheng Y et al (2018) The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients 10:375PubMedPubMedCentralCrossRef

355.

Jafari T, Fallah AA, Barani A (2016) Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Clin Nutr 35:1259–1268PubMedCrossRef

356.

Mousa A, Naderpoor N, Teede H et al (2018) Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 76:380–394PubMedCrossRef

357.

Lee KJ, Lee YJ (2016) Effects of vitamin D on blood pressure in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 54:233–242PubMedCrossRef

358.

Yu Y, Tian L, Xiao Y et al (2018) Effect of vitamin D supplementation on some inflammatory biomarkers in type 2 diabetes mellitus subjects: a systematic review and meta-analysis of randomized controlled trials. Ann Nutr Metab 73:62–73PubMedCrossRef

359.

Verma H, Garg R (2017) Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 30:621–633PubMedCrossRef

360.

Asbaghi O, Moradi S, Kashkooli S et al (2022) The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr 128:2363–2372PubMedCrossRef

361.

Asbaghi O, Hosseini R, Boozari B et al (2021) The effects of magnesium supplementation on blood pressure and obesity measure among type 2 diabetes patient: a systematic review and meta-analysis of randomized controlled trials. Biol Trace Elem Res 199:413–424PubMedCrossRef

362.

Vincent JB (2000) Elucidating a biological role for chromium at a molecular level. Acc Chem Res 33:503–510PubMedCrossRef

363.

Asbaghi O, Fatemeh N, Mahnaz RK et al (2020) Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 161:105098PubMedCrossRef

364.

Yin RV, Phung OJ (2015) Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutr J 14:14PubMedPubMedCentralCrossRef

365.

Suksomboon N, Poolsup N, Yuwanakorn A (2014) Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther 39:292–306PubMedCrossRef

366.

Chimienti F (2013) Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 26:1–11PubMedCrossRef

367.

de Carvalho GB (2017) Zinc’s role in the glycemic control of patients with type 2 diabetes: a systematic review. Biometals 30:161–162CrossRef

368.

Fernández-Cao JC, Warthon-Medina M, Hall Moran V et al (2018) Dietary zinc intake and whole blood zinc concentration in subjects with type 2 diabetes versus healthy subjects: a systematic review, meta-analysis and meta-regression. J Trace Elem Med Biol 49:241–251PubMedCrossRef

369.

Wang X, Wu W, Zheng W et al (2019) Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 110:76–90PubMedCrossRef

370.

Asbaghi O, Sadeghian M, Fouladvand F et al (2020) Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 30:1260–1271PubMedCrossRef

371.

Rahimi R, Nikfar S, Larijani B et al (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365–373PubMedCrossRef

372.

Ashor AW, Werner AD, Lara J et al (2017) Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr 71:1371–1380PubMedCrossRef

373.

Xu R, Zhang S, Tao A et al (2014) Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials. PLoS One 9:e95008PubMedPubMedCentralCrossRef

374.

Khodaeian M, Tabatabaei-Malazy O, Qorbani M et al (2015) Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study. Eur J Clin Invest 45:1161–1174PubMedCrossRef

375.

Montero D, Walther G, Stehouwer CDA et al (2014) Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15:107–116PubMedCrossRef

376.

Tabatabaei-Malazy O, Ardeshirlarijani E, Namazi N et al (2019) Dietary antioxidative supplements and diabetic retinopathy; a systematic review. J Diabetes Metab Disord 18:705–716PubMedPubMedCentralCrossRef

377.

Jeyaraman MM, Al-Yousif NSH, Singh Mann A et al (2020) Resveratrol for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 1:CD11919PubMed

378.

Palma-Duran SA, Vlassopoulos A, Lean M et al (2017) Nutritional intervention and impact of polyphenol on glycohemoglobin (HbA1c) in non-diabetic and type 2 diabetic subjects: Systematic review and meta-analysis. Crit Rev Food Sci Nutr 57:975–986PubMedCrossRef

379.

Fogacci F, Tocci G, Presta V et al (2019) Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr 59:1605–1618PubMedCrossRef

380.

Drzikova B (2005) Haferprodukte mit modifiziertem Gehalt an β‑Glucanen und resistenter Stärke und ihre Effekte auf den Gastrointestinaltrakt unter In-vitro- und In-vivo-Bedingungen. http://opus.kobv.de/ubp/volltexte/205/592/ (Erstellt: 12. Juni 2023)

381.

He L, Zhao J, Huang Y et al (2016) The difference between oats and beta-glucan extract intake in the management of HbA1c, fasting glucose and insulin sensitivity: a meta-analysis of randomized controlled trials. Food Funct 7:1413–1428PubMedCrossRef

382.

Abbasi NN, Purslow PP, Tosh SM et al (2016) Oat β‑glucan depresses SGLT1-and GLUT2-mediated glucose transport in intestinal epithelial cells (IEC-6). Nutr Res 36:541–552PubMedCrossRef

383.

Wang F, Yu G, Zhang Y et al (2015) Dipeptidyl Peptidase IV Inhibitory Peptides Derived from Oat (Avena sativa L.), Buckwheat (Fagopyrum esculentum), and Highland Barley (Hordeum vulgare trifurcatum (L.) Trofim) Proteins. J Agric Food Chem 63:9543–9549PubMedCrossRef

384.

Liu M, Zhang Y, Zhang H et al (2016) The anti-diabetic activity of oat β‑d-glucan in streptozotocin-nicotinamide induced diabetic mice. Int J Biol Macromol 91:1170–1176PubMedCrossRef

385.

Lammert A, Kratzsch J, Selhorst J et al (2008) Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study. Exp Clin Endocrinol Diabetes 116:132–134PubMedCrossRef

386.

Delgado G, Kleber ME, Krämer BK et al (2019) Dietary intervention with oatmeal in patients with uncontrolled type 2 diabetes mellitus—a crossover study. Exp Clin Endocrinol Diabetes 127:623–629PubMedCrossRef

387.

Delgado GE, Krämer BK, Scharnagl H et al (2020) Bile acids in patients with uncontrolled type 2 diabetes mellitus—the effect of two days of oatmeal treatment. Exp Clin Endocrinol Diabetes 128:624–630PubMedCrossRef

388.

Behall KM, Scholfield DJ, Hallfrisch J (2005) Comparison of hormone and glucose responses of overweight women to barley and oats. J Am Coll Nutr 24:182–188PubMedCrossRef

389.

Braaten JT, Scott FW, Wood PJ et al (1994) High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 11:312–318PubMedCrossRef

390.

Pick ME, Hawrysh ZJ, Gee MI et al (1996) Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96:1254–1261PubMedCrossRef

391.

Tapola N, Karvonen H, Niskanen L et al (2005) Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 15:255–261PubMedCrossRef

392.

Tappy L, Gügolz E, Würsch P (1996) Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19:831–834PubMedCrossRef

393.

Wood PJ, Beer MU, Butler G (2000) Evaluation of role of concentration and molecular weight of oat beta-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load. Br J Nutr 84:19–23PubMedCrossRef

394.

Anonym]. Scientific Opinion on the substantiation of health claims related to beta glucans and maintenance or achievement of normal blood glucose concentrations (ID 756, 802, 2935) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFS2 2010; 8: 1482

395.

Amtsblatt der Europäischen Union (2011) L 136/1 vom 25.05.2012. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ (Erstellt: 4. Juli 2021)

396.

Zurbau A, Noronha JC, Khan TA et al (2021) The effect of oat β‑glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. Eur J Clin Nutr 75:1540–1554PubMedPubMedCentralCrossRef

397.

Battilana P, Ornstein K, Minehira K et al (2001) Mechanisms of action of betaglucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 55:327–333PubMedCrossRef

398.

Jenkins AL, Jenkins DJA, Zdravkovic U et al (2002) Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr 56:622–628PubMedCrossRef

399.

Asbaghi O, Moradi S, Kashkooli S et al (2022) The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr 20:1–10

Springer Medizin

Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus

Auszug

Passend zum Thema

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Vitamin-B12-Mangel durch Arzneimittel

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.